ROLE OF SNAPIN-MEDIATED LYSOSOMAL REGULATION IN ALZHEIMER'S DISEASE PATHOGENESIS
SNAP 介导的溶酶体调节在阿尔茨海默病发病机制中的作用
基本信息
- 批准号:8661657
- 负责人:
- 金额:$ 24.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:Aging-Related ProcessAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAmyloidAmyloid beta-Protein PrecursorAmyloid depositionAutophagocytosisBiologicalBrainCell physiologyCellsDefectDepositionDevelopmentDiseaseDynein ATPaseFunctional disorderGenesGeneticGoalsHomeostasisInstructionKnowledgeLeadLifeLinkLysosomesMediatingMembrane Protein TrafficMitochondriaMolecularMotorMusNerve DegenerationNeuraxisNeurodegenerative DisordersNeuronsOrganellesOutcome StudyPathogenesisPathologyPathway interactionsPatientsPeptidesPlayPreventionPreventiveProcessProductionQuality ControlRegulationResearchRoleSNAPIN geneSynapsesSystemTestingTherapeuticTransgenic MiceTranslational ResearchUp-RegulationWorkage relatedagedamyloid precursor protein processingamyloidogenesisbaseendosome membranefightinginnovationinsightlate endosomemitochondrial dysfunctionmouse modelneuropathologynovelnovel therapeuticsprotein aggregateprotein metabolismprotein transportresearch studyretrograde transporttrafficking
项目摘要
The autophagy-lysosomal pathway is essential for neuronal homeostasis. Defects within this pathway have
been directly linked to a growing number of neurodegenerative diseases. Lysosomal dysfunction is one of
the main cellular defects contributing to the onset and progression of Alzheimer's Disease (AD). However, it
is unclear if altered late endocytic trafficking leads to the aberrant increase of Amyloid Precursor Protein
(APP) amyloidogenic processing, and thereby results in the accumulation of Amyloid p-peptide (Ap) in
patient brains. The goal of this work is to define the role of an up-regulated late endocytic pathway in APP
processing and Ap accumulation during the onset and progression of AD. My central hypothesis is that
autophagy-lysosomal function is a critical step required to regulate the activity of the amyloidogenic
machinery and, thus, control Ap deposition in AD brains. Using mouse genetic and cell biological
approaches combined with gene rescue experiments in live neurons, we established that Snapin coordinates
retrograde transport of late endosomes and membrane trafficking ofthe late endocytic pathway, thus
highlighting a novel mechanism for up-regulating neuronal autophagy-lysosomal function. The contribution of
this study is expected to advance our knowledge and provide mechanistic insights into how Snapin-mediated
up-regulation of late endosome-lysosomal trafficking controls APP metabolism and Ap deposition, and
eliminates damaged mitochondria in the brain of AD models. The identified mechanisms are expected to
provide new concepts leading to preventive and therapeutic strategies that will benefit the growing number of
AD patients who have either Ap deposition or lysosomal pathology and mitochondrial dysfunction in the
central nervous system. It is expected that the findings from the proposed study will ultimately be applicable
to the prevention and treatment of many age-related neurodegenerative diseases associated with the
accumulation of protein aggregates and dysfunctional lysosomes and mitochondria. This work is consistent
with the longstanding commitment ofthe NIA to understand the aging process and fight age-related
neurodegenerative diseases.
自噬 - 溶酶体途径对于神经元体内平衡至关重要。该路径内的缺陷
与越来越多的神经退行性疾病直接相关。溶酶体功能障碍是
主要的细胞缺陷导致阿尔茨海默氏病(AD)的发作和进展。但是,它
目前尚不清楚晚期内吞运输是否会导致淀粉样前体蛋白异常增加
(APP)淀粉样蛋白生成加工,从而导致淀粉样蛋白P肽(AP)在
病人的大脑。这项工作的目的是定义应用中上调的晚期内吞途径的作用
AD发作和进展过程中的处理和AP积累。我的中心假设是
自噬 - 溶酶体功能是调节淀粉样蛋白酶活性所需的关键步骤
机械,从而控制AD大脑中的AP沉积。使用小鼠遗传和细胞生物学
方法与活神经元中的基因救援实验结合在一起,我们确定了Snapin坐标
后期内体的逆行运输和晚期内吞途径的膜运输,因此
突出了一种新的机制,用于上调神经元自噬溶质体功能。的贡献
预计这项研究将提高我们的知识,并提供有关Snapin介导的方式的机械见解
晚期内体 - 赖斯体贩运控制的上调APP代谢和AP沉积,以及
消除了AD模型大脑中的线粒体受损。预计确定的机制将
提供新的概念,导致预防和治疗策略,将有益于日益增长的数量
患有AP沉积或溶酶体病理学和线粒体功能障碍的AD患者
中枢神经系统。预计拟议研究的发现最终将适用
预防和治疗许多与年龄有关的神经退行性疾病
蛋白质聚集体和功能障碍溶酶体和线粒体的积累。这项工作是一致的
NIA长期承诺了解衰老过程并与年龄有关
神经退行性疾病。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Qian Cai其他文献
Qian Cai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Qian Cai', 18)}}的其他基金
Defining the Function of RME-8 in Endosomal Regulation During Health and Disease
定义 RME-8 在健康和疾病期间内体调节中的功能
- 批准号:
10565681 - 财政年份:2020
- 资助金额:
$ 24.5万 - 项目类别:
Defining the Function of RME-8 in Endosomal Regulation During Health and Disease
定义 RME-8 在健康和疾病期间内体调节中的功能
- 批准号:
10093100 - 财政年份:2020
- 资助金额:
$ 24.5万 - 项目类别:
Defining the Function of RME-8 in Endosomal Regulation During Health and Disease
定义 RME-8 在健康和疾病期间内体调节中的功能
- 批准号:
10334441 - 财政年份:2020
- 资助金额:
$ 24.5万 - 项目类别:
Defining the Function of RME-8 in Endosomal Regulation During Health and Disease
定义 RME-8 在健康和疾病期间内体调节中的功能
- 批准号:
10387416 - 财政年份:2020
- 资助金额:
$ 24.5万 - 项目类别:
Regulation of Mitochondrial Quality Through Mitophagy in Alzheimer's Disease
阿尔茨海默病中通过线粒体自噬调节线粒体质量
- 批准号:
8916202 - 财政年份:2014
- 资助金额:
$ 24.5万 - 项目类别:
Regulation of Mitochondrial Quality Through Mitophagy in Alzheimer's Disease
阿尔茨海默病中通过线粒体自噬调节线粒体质量
- 批准号:
9308029 - 财政年份:2014
- 资助金额:
$ 24.5万 - 项目类别:
REGULATION OF MITOCHONDRIAL QUALITY THROUGH MITOPHAGY IN ALZHEIMER'S DISEASE
阿尔茨海默病中通过线粒体自噬调节线粒体质量
- 批准号:
10414056 - 财政年份:2014
- 资助金额:
$ 24.5万 - 项目类别:
REGULATION OF MITOCHONDRIAL QUALITY THROUGH MITOPHAGY IN ALZHEIMER'S DISEASE
阿尔茨海默病中通过线粒体自噬调节线粒体质量
- 批准号:
10605275 - 财政年份:2014
- 资助金额:
$ 24.5万 - 项目类别:
Regulation of Mitochondrial Quality Through Mitophagy in Alzheimer's Disease
阿尔茨海默病中通过线粒体自噬调节线粒体质量
- 批准号:
8801326 - 财政年份:2014
- 资助金额:
$ 24.5万 - 项目类别:
REGULATION OF MITOCHONDRIAL QUALITY THROUGH MITOPHAGY IN ALZHEIMER'S DISEASE
阿尔茨海默病中通过线粒体自噬调节线粒体质量
- 批准号:
10183338 - 财政年份:2014
- 资助金额:
$ 24.5万 - 项目类别:
相似海外基金
Regulation of microglial function by blood-borne factors
血源性因子对小胶质细胞功能的调节
- 批准号:
10679408 - 财政年份:2023
- 资助金额:
$ 24.5万 - 项目类别:
The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
- 批准号:
10678125 - 财政年份:2023
- 资助金额:
$ 24.5万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 24.5万 - 项目类别:
Behavioral and physiological measurements of hearing in mouse models of Alzheimer's Disease
阿尔茨海默病小鼠模型听力的行为和生理测量
- 批准号:
10647340 - 财政年份:2023
- 资助金额:
$ 24.5万 - 项目类别: